Mohan Pankaj - Insider Non-Derivative Transactions at Sonnet BioTherapeutics Holdings, Inc. (SONN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Oct 27, 2023, Mohan Pankaj's relationship to Sonnet BioTherapeutics Holdings, Inc. (SONN) is Director,Officer (Chairman, President and CEO), and currently has 59,526 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SONN insiders.
Data Source: SEC.
Mohan Pankaj - Insider Non-Derivative Transactions of SONN Common Stock
Mohan Pankaj - Insider Non-Derivative Transactions at SONN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 28, 2023 | P -- (Common Stock) | 34375 | 0 | 59526 |
| May 16, 2023 | P -- (Common Stock) | 371600 | 0.22 | 553331 |
| Mar 16, 2023 | P -- (Common Stock) | 60000 | 0.59 | 181731 |
| Jan 8, 2023 | Disposition -- (Common Stock) | 73561 | 0 | 48170 |
| Jan 8, 2023 | Acquisition -- (Common Stock) | 73561 | 0 | 121731 |